UBS Group
MEDP icon

UBS Group’s Medpace MEDP Stock Holding History

UBS Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161M Sell
303,926
-36,507
-11% -$16.8M 0.02% 795
2026
Q1 		$163M Buy
340,433
+11,554
+4% +$5.92M 0.02% 719
2025
Q4 		$185M Buy
328,879
+81,250
+33% +$46.1M 0.03% 613
2025
Q3 		$127M Sell
247,629
-26,053
-10% -$11.4M 0.02% 865
2025
Q2 		$85.9M Buy
273,682
+87,211
+47% +$26.2M 0.01% 1082
2025
Q1 		$56.8M Buy
186,471
+26,127
+16% +$8.79M 0.01% 1365
2024
Q4 		$53.3M Buy
160,344
+98,393
+159% +$33.4M 0.01% 1411
2024
Q3 		$20.7M Sell
61,951
-7,815
-11% -$2.97M ﹤0.01% 1798
2024
Q2 		$28.7M Buy
69,766
+18,471
+36% +$7.31M 0.01% 1404
2024
Q1 		$20.7M Buy
51,295
+38,004
+286% +$13.4M 0.01% 1656
2023
Q4 		$4.07M Buy
13,291
+2,254
+20% +$608K ﹤0.01% 3004
2023
Q3 		$2.67M Sell
11,037
-477
-4% -$122K ﹤0.01% 3167
2023
Q2 		$2.77M Buy
11,514
+402
+4% +$83.5K ﹤0.01% 3213
2023
Q1 		$2.09M Sell
11,112
-12,784
-53% -$2.64M ﹤0.01% 3392
2022
Q4 		$5.08M Buy
23,896
+15,513
+185% +$3.1M ﹤0.01% 2493
2022
Q3 		$1.32M Buy
8,383
+863
+11% +$138K ﹤0.01% 3507
2022
Q2 		$1.13M Sell
7,520
-5,371
-42% -$778K ﹤0.01% 3636
2022
Q1 		$2.11M Sell
12,891
-28,348
-69% -$4.67M ﹤0.01% 3379
2021
Q4 		$8.98M Buy
41,239
+20,895
+103% +$4.38M ﹤0.01% 2244
2021
Q3 		$3.85M Buy
20,344
+10,106
+99% +$1.84M ﹤0.01% 2951
2021
Q2 		$1.81M Sell
10,238
-16,552
-62% -$2.86M ﹤0.01% 3668
2021
Q1 		$4.39M Sell
26,790
-4,816
-15% -$737K ﹤0.01% 2755
2020
Q4 		$4.4M Buy
31,606
+5,582
+21% +$704K ﹤0.01% 2591
2020
Q3 		$2.91M Buy
26,024
+5,119
+24% +$592K ﹤0.01% 2705
2020
Q2 		$1.94M Buy
20,905
+17,202
+465% +$1.46M ﹤0.01% 2897
2020
Q1 		$272K Sell
3,703
-1,421
-28% -$123K ﹤0.01% 4470
2019
Q4 		$431K Buy
5,124
+577
+13% +$44.7K ﹤0.01% 4967
2019
Q3 		$382K Buy
4,547
+1,622
+55% +$123K ﹤0.01% 4770
2019
Q2 		$191K Sell
2,925
-1,083
-27% -$62.4K ﹤0.01% 4943
2019
Q1 		$237K Sell
4,008
-16,936
-81% -$1.01M ﹤0.01% 4511
2018
Q4 		$1.11M Buy
20,944
+2,498
+14% +$137K ﹤0.01% 3582
2018
Q3 		$1.1M Sell
18,446
-227,171
-92% -$12.4M ﹤0.01% 3751
2018
Q2 		$10.6M Sell
245,617
-77,690
-24% -$3.14M ﹤0.01% 1702
2018
Q1 		$11.3M Buy
323,307
+312,420
+2,870% +$11.4M ﹤0.01% 1580
2017
Q4 		$395K Buy
10,887
+6
+0.1% +$210 ﹤0.01% 4455
2017
Q3 		$347K Buy
10,881
+8,748
+410% +$267K ﹤0.01% 4487
2017
Q2 		$62K Buy
2,133
+948
+80% +$26.6K ﹤0.01% 5504
2017
Q1 		$36K Sell
1,185
-884
-43% -$28.5K ﹤0.01% 5743
2016
Q4 		$75K Buy
2,069
+1,969
+1,969% +$65.6K ﹤0.01% 5499
2016
Q3 		$3K Buy
+100
New +$2.92K ﹤0.01% 7288

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

UBS Group's MEDP Position: Q2 2026 in Review

UBS Group reduced its Medpace (MEDP) stake by 11% in Q2 2026, selling an estimated $16.8M and leaving 303,926 shares worth $161M. The position accounts for 0.02% of the portfolio, ranked #795.

UBS Group first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $185M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • UBS Group held 303,926 shares of Medpace worth $161M as of Q2 2026.
  • UBS Group sold 36,507 Medpace shares in Q2 2026, an estimated $16.8M.
  • Medpace made up 0.02% of UBS Group's portfolio in Q2 2026, its #795 holding.
  • UBS Group first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
  • UBS Group's Medpace position peaked at $185M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.